[82] developed a self-assembled, pH-degradable TLR7/8 agonist-ligated nanoparticle carrier (IMDQnano) that can protect TLR7/8 agonist from systemic bio-distribution and unfavorable degradation, while retaining the valid anti-tumor efficacy of localized IMDQ treatment. Here, TLR7 is linked to neoplasm.